$ESPR

Esperion Therapeutics Inc.

  • NASDAQ/NMS (GLOBAL MARKET)
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$25.55 -

Extented Hours

VOLUME

1,072,731

DAY RANGE

25.54 - 26.84

52 WEEK

24.2 - 73.84

Key Metrics

Market Cap

712.25 M

Beta

1.04

Avg. Volume

815.46 K

Shares Outstanding

27.88 M

Yield

0%

Public Float

0

Next Earnings Date

Next Dividend Date

Company Information

CEO: Timothy Mayleben

Website:

HQ: 3891 Ranchero Dr Ste 150 Ann arbor, 48108-2837 Michigan

Related News

  • Benzinga

    Why Novartis, BioVie, Esperion And VBI Are Moving Today

    15 Jan 2021, 16:47
  • Benzinga

    Why BioLine, Esperion And More Are Moving Today

    16 Dec 2020, 16:40
  • Benzinga

    The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings

    04 Nov 2020, 13:21
  • Seeking Alpha

    Esperion Therapeutics, Inc. (ESPR) CEO Tim Mayleben on Q3 2020 Results - Earnings Call Transcript

    03 Nov 2020, 02:58
  • Stock Observer

    Esperion Therapeutics (NASDAQ:ESPR) Stock Rating Upgraded by BidaskClub

    20 Oct 2020, 02:38